Clearmind Medicine Acquires 51% Stake in Charging Robotics

September 4, 2026

Clearmind Medicine entered into a definitive agreement to acquire a 51% stake in Charging Robotics for $2.5 million and provide the company with a separate $1.5 million loan bearing 4% interest. The acquisition was expected to close during the week of September 7, 2026, subject to closing conditions; a later report still described completion as pending.

Buyers
Clearmind Medicine Inc.
Targets
Charging Robotics
Industry
Manufacturing
Location
Tel Aviv District, Israel
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.